Loading clinical trials...
Loading clinical trials...
A Phase II Trial Assessing the Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer.
Conditions
Interventions
Capecitabine, Oxaliplatin
Locations
1
United Kingdom
Royal Marsden Hospital
Sutton, Surrey, United Kingdom
Start Date
August 1, 2002
Last Updated
January 6, 2010
NCT06696768
NCT04704661
NCT05489211
NCT06625775
NCT04657068
NCT06445062
Lead Sponsor
Royal Marsden NHS Foundation Trust
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions